BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oculopharyngeal Muscular Dystrophy (OPMD)

  March 10, 2026

   · 

  6 min read
• Press Releases

  NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant in Charcot-Marie-Tooth disease Types 1 & 2

  March 10, 2026

   · 

  8 min read
• Press Releases

  Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026

  March 10, 2026

   · 

  12 min read
• Press Releases

  Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update

  March 10, 2026

   · 

  11 min read
• Press Releases

  Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

  March 10, 2026

   · 

  9 min read
• Press Releases

  Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

  March 10, 2026

   · 

  4 min read
• Press Releases

  Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

  March 10, 2026

   · 

  14 min read
• Press Releases

  Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

  March 10, 2026

   · 

  16 min read
• Press Releases

  Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

  March 10, 2026

   · 

  10 min read
• Press Releases

  Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference

  March 10, 2026

   · 

  7 min read